vimarsana.com
Home
Live Updates
KalVista Pharmaceuticals, Inc.: KalVista Pharmaceuticals Presents Data at Western Society of Allergy, Asthma & Immunology (WSAAI) 60th Annual Scientific Session : vimarsana.com
KalVista Pharmaceuticals, Inc.: KalVista Pharmaceuticals Presents Data at Western Society of Allergy, Asthma & Immunology (WSAAI) 60th Annual Scientific Session
Oral sebetralstat regimen for short-term prophylaxis to be evaluated in KONFIDENT-S Positive phase 1 sebetralstat data supports KONFIDENT trial expansion to Japan KalVista Pharmaceuticals, Inc. (NASDAQ:
Related Keywords
Japan ,
United States ,
Cambridge ,
Cambridgeshire ,
United Kingdom ,
Japanese ,
Paulk Audhya ,
Marca Riedl ,
Jarrod Aldom ,
Schwierige Zeiten ,
Matthew Iverson ,
Division Of Rheumatology ,
Nasdaq ,
Society Of Allergy ,
Kalvista Pharmaceuticals Inc ,
Exchange Commission ,
University Of California San Diego ,
Corporate Communications ,
Vista Pharmaceuticals ,
Western Society ,
Asthma Immunology ,
Annual Scientific Session ,
Literature Review ,
Preprocedural Prevention ,
Patients With Hereditary Angioedema ,
California San Diego ,
Safety Profile ,
Healthy Japanese ,
White Adults ,
Results From ,
Placebo Controlled Trial ,
Oral Plasma Kallikrein Inhibitor Sebetralstat ,
Attack Location ,
Kalvista Pharmaceuticals ,
Securities Litigation Reform Act ,
Kalvista ,
Pharmaceuticals ,
Presents ,
Data ,
Western ,
Society ,
Allergy ,
Asthma ,
Mmunology ,
Esaai ,
0th ,
Nnual ,
Cientific ,
Session ,
vimarsana.com © 2020. All Rights Reserved.